Stem cell therapy - Building reproducible and scalable workflows

Stem cell therapy is one of the most promising areas of regenerative medicine, but successful translation depends on more than the biological potential of stem cells. Variability introduced during cell sourcing, expansion, differentiation, cryopreservation, and quality control can affect reproducibility, scalability, and downstream manufacturing.

This infographic explores the key stages of stem cell therapy development and highlights practical considerations for building robust stem cell workflows. Discover how workflow design, culture conditions, material selection, and early scalability planning can help support more consistent outcomes and smoother transition toward GMP manufacturing.

In this infographic, you'll learn about:

• Key stem cell platforms used in stem cell therapy development
• The critical stages of a stem cell workflows, from cell sourcing to quality control
• Common sources of variability in stem cell culture and manufacturing workflows
• Practical strategies for improving reproducibility and process robustness
• The role of serum-free and animal component-free systems in supporting translation and GMP readiness
• Key considerations for building scalable stem cell workflows from research through process development

Download this infographic to explore how robust workflow design can support reproducible and scalable stem cell therapy development.